| 1 |
27563480 | Impact of Rosuvastatin Treatment on HDL-Induced PKC-βII and eNOS Phosphorylation in Endothelial Cells and Its Relation to Flow-Mediated Dilatation in Patients with Chronic Heart Failure. | 2016 |
2 |
| 2 |
25453767 | HMG-CoA reductase inhibitor rosuvastatin improves abnormal brain electrical activity via mechanisms involving eNOS. | 2015 Jan 22 |
6 |
| 3 |
23648561 | Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders. | 2013 Jul 5 |
1 |
| 4 |
23768697 | Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells. | 2013 Jul |
1 |
| 5 |
22799578 | The role of nitric oxide on rosuvastatin-mediated S-nitrosylation and translational proteomes in human umbilical vein endothelial cells. | 2012 Jul 16 |
1 |
| 6 |
18162361 | Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice. | 2009 Jan |
1 |
| 7 |
17928646 | Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells. | 2007 Sep |
2 |
| 8 |
17357484 | The protective effect of rosuvastatin on ischemic brain injury and its mechanism. | 2006 |
1 |
| 9 |
16165089 | Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells. | 2005 Nov 4 |
4 |